For those dealing with fatty liver disease, there’s welcome news to report. Earlier this year, the United States Food and ...

Chronic hepatitis C infections have fallen in people who inject drugs in the last 6 years. The latest data from the UK Health ...

Hepatitis, an inflammation of the liver caused by viral infections or other factors, remains a significant global health ...

Request To Download Free Sample of This Strategic Report @ The publisher has been vigilantly tracking the diverse markets within Saudi Arabia. This report presents an extensive analysis, encompassing ...

Shares of Cumberland Pharmaceuticals (CPIX) doubled on Tuesday morning, reaching levels not seen since March 2023, following ...

DOVER, Del. and EPALINGES, Switzerland, Dec. 11, 2024 /PRNewswire/ -- Pilatus Biosciences Inc. announced that the U.S. Food ...

In the trail, 11 participants in the azelaprag group exhibited transaminase elevations without significant symptoms.

The struggling biotech company is looking to break into the lucrative hepatitis C market with the promise of an easier ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...

This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024 ...

Shares of Cumberland Pharmaceuticals were trading higher in the after-hours market after the company said the Food and Drug Administration approved a supplemental new drug application for liver drug ...

Atea Pharmaceuticals reports 98% SVR12 in a Phase 2 hepatitis C study, supporting an eight-week treatment plan with ...